This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Université Henri Poincaré-Nancy I. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2010
Title: Carlos Contreras-Martel: Innovator in Phosphate-Binding Proteins
Introduction
Carlos Contreras-Martel is a notable inventor based in Saint-Égrève, France. He has made significant contributions to the field of biochemistry, particularly in the development of proteins that bind phosphate. His innovative work has led to the creation of a patent that holds promise for pharmaceutical applications.
Latest Patents
Carlos holds a patent for a phosphate-binding protein, which includes pharmaceutical compositions containing the same and their uses. The patent describes a protein that can be formed by various sequences derived from a specific sequence, SEQ ID NO: 1. This protein is designed to bind to phosphate, with variations that include substitutions, removals, or additions of amino acids. The patent also covers homologous sequences and fragments that maintain the ability to bind to phosphate, ensuring versatility in its applications.
Career Highlights
Throughout his career, Carlos has worked with esteemed institutions such as Université Henri Poincaré-Nancy I and the Centre National de la Recherche Scientifique. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Carlos has collaborated with notable scientists, including Juan Fontecilla-Camps and Eric Chabriere. These partnerships have enriched his research and fostered innovation in the field of biochemistry.
Conclusion
Carlos Contreras-Martel is a distinguished inventor whose work on phosphate-binding proteins has the potential to impact pharmaceutical science significantly. His contributions reflect a commitment to advancing knowledge and technology in biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile